Open
Accelerate Program for Quebec Emerging Companies
Last Update: March 24, 2026
Quebec, Canada
Support for Therapeutics, Med-Tech and Digital Health innovators
Expert Advice
Overview
Get customized support and discounted rate on rental fees for lab and office spaces to help you advance to significant seed or Series A financing, if you’re an early-stage life sciences business.
At a glance
Funding available
Financing goals
- No objectives are currently available
Eligible Funding
- No Condition
Timeline
- Open Date : August 20, 2021
Eligible candidates
Eligible Industries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
Location
- Quebec
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Startups
Activities funded
Examples of admissible projects:
$ 750,000
Developing early-stage diagnostics technology for infectious diseases
$ 800,000
Development of a novel gene therapy for rare genetic disorders
$ 600,000
Collaborative research with University of Ottawa on cancer biomarker discovery
$ 1,100,000
Collaborative effort with Canadian researchers on revolutionary diabetes treatment
$ 1,200,000
Translation of academic research to therapeutic products for Alzheimer's disease
$ 1,000,000
Initial development of a biodegradable nano-coating for medical implants
Eligibility
Eligibility for this grant is determined by specific requirements related to the applicant's profile and proposed activities.
- The company must be part of the Canadian life sciences sector, focusing on biopharmaceuticals, medical devices, or digital health solutions.
- The technology proposed must demonstrate differentiation and a competitive advantage.
- The market opportunity for the technology must be significant.
- The company must have a high-quality team in place.
- The scope and strength of IP coverage must be clear and defendable.
- The proposed project must offer a potential return on investment.
- The seed investment must be capable of bringing the company to a value inflection point attractive to private capital.
Who is eligible?
Academic researchers and emerging Canadian life sciences companies focused on biopharmaceuticals, medical devices, and digital health solutions can apply for this grant. AdMare seeks projects involving novel and transformative pre-clinical technologies with commercial potential that address unmet medical needs.Eligible expenses
adMare provides opportunities for collaborations that transform academic research into new therapeutic products and bio-innovation companies. The eligible projects focus on early-stage technology development and company-building in the life sciences sector.
- Collaboration with researchers to translate leading academic research into therapeutics and health innovations.
- Identification and advancement of pre-clinical technologies addressing unmet medical needs.
- Creation of new Canadian life sciences companies by partnering with scientists and entrepreneurs.
- Development of a business case to attract private sector investment.
- Support for growth of existing life sciences companies through shared expertise and investment capital.
Selection criteria
The evaluation and selection criteria for projects under this grant focus on ensuring alignment with adMare's strategic investment goals.
- Differentiation and competitive advantage of the technology.
- Market opportunity and potential for growth.
- Quality and experience of the team involved.
- Scope and strength of intellectual property coverage.
- Potential return on investment.
- The impact of an adMare seed investment in building the company to a value inflection point that attracts private capital.
How to apply
1
Identification of opportunities
- Assess the relevance of your project against adMare's investment criteria.
- Verify the differentiation, competitive advantage, and commercial opportunity of your technology.
2
Preparation of the request
- Assemble an experienced management team and a scientific team.
- Develop a comprehensive and convincing business case.
- Prepare supporting documentation, including research data and a business strategy.
3
Submission of the request
- Contact adMare for specific instructions on the submission process.
- Submit your application electronically or according to the instructions provided by adMare.
Documents and links
Contacts
514.375.3334
